Background: The blood vessel hemophilia factor (vWF) is the blood vessel endothelial cell and the marrow megalokaryocyte synthesis one kind of glycoprotein, stops bleeding in 1 issue and 2 issues all is playing the vital role, if will lack causes the patient to have the blood vessel hemophilia (vWD) vWF to be possible to decompose by ADAMTS13 loses activeness, the hemoglutination enzyme sensitive protein -1 possibly participation this adjustment process vWF level the many kinds of heredities and the environmental factor influence, ABO blood-group influence was bigger vWF mainly through A1 and the A3 area and blood platelet GP 1b and the collagen union, in stopped bleeding with the thrombus forming process in the vital role, And with heart, blood vessel of brain disease and blood vessel newborn close correlation, therefore studies vWF the biology characteristic and the function has the vital significance.
Description: Rabbit polyclonal to VWF
Immunogen: KLH conjugated synthetic peptide derived from VWF
Specificity: ·Reacts with Human, Mouse and Rat.
·Isotype: IgG
Application: ·Western blotting: 1/100-500. Predicted Mol wt: 309 kDa;
·Immunohistochemistry (Paraffin/frozen tissue section): 1/50-200;
·Immunocytochemistry/Immunofluorescence: 1/100;
·Immunoprecipitation: 1/50;
·ELISA: 1/500;
·Optimal working dilutions must be determined by the end user.
